Cellares
Cellares develops and operates integrated technologies for automated cell therapy manufacturing and quality control that help biopharmaceutical partners scale development to industrial production. The company’s offerings include the Cell Shuttle platform for end-to-end automation of the cell therapy manufacturing process and the Cell Q platform for automated quality control, supported by integrated software and consumable cartridges. Cellares positions itself as an Integrated Development and Manufacturing Organization that supports process transfer, scalable production, and regulatory pathways for clinical and commercial programs. Its services enable clients to transition manual processes onto automated systems and expand manufacturing capacity to meet broader patient demand.
Domain
cellares.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$257.0M
Founded
2018
Tech Stack (22 technologies)
Frequently Asked Questions
What technologies does Cellares use?+
Cellares uses 22 technologies including HubSpot, List.js, OWL Carousel.
What industry is Cellares in?+
Cellares operates in the Biotechnology industry.
Where is Cellares based?+
Cellares is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026